Dr. Radcliffe Thomas

Matthew Weir is a Nephrologist in Baltimore, Maryland. Dr. Weir is highly rated in 10 conditions, according to our data. His top areas of expertise are High Potassium Level, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy.

Daniel C. Brennan, M.D., joins the Johns Hopkins Division of Renal Medicine as professor of nephrology and medical director of the Comprehensive Transplant Center. Dr. Brennan’s areas of clinical expertise include transplant nephrology and renal disease. Prior to joining Johns Hopkins, Dr. Brennan was the Alan A. and Edith L. Wolff Professor of renal Diseases at Washington University and the Director of Transplant Nephrology at the Washington University School of Medicine. He received his undergraduate degree from Cornell College and earned his medical degree at the University of Iowa, where he completed a residency in internal medicine. He then completed research and clinical nephrology fellowships at Brigham & Women’s Hospital/Harvard Medical School. Dr. Brennan holds professional memberships at various organizations, including the American College of Physicians, the International Society of Nephrology, the American Society of Nephrology, The Transplantation Society, the American Society of Transplant Physicians and the American Society of Clinical Investigation. Dr. Brennan is highly rated in 11 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Kidney Transplant, and Pancreas Transplant.

Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is highly rated in 10 conditions, according to our data. His top areas of expertise are Interstitial Nephritis, Prerenal Azotemia, Acute Tubular Necrosis, Kidney Transplant, and Nephrectomy.